Latest filing published 16 May 2018 for Adma Biologics, INC..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +82.2%Entry US$2.75 · Close at T+365 US$5.01
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Biotest AG: trading record in brief
This profile gathers the share dealings of Biotest AG in Adma Biologics, Inc. The record holds 3 filings, for trades running from 9 November 2017 to 14 May 2018.
Both buying and selling appear: 2 purchases worth €21.6M, against 1 sale. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2018 alone, the filings show no purchases and 1 sale.
The record was last updated on 16 May 2018 with an open-market sale in Adma Biologics, Inc. The last insider purchase was made public on 16 November 2017, 3,280 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Biotest AG
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,591,160 shares0Non-Voting Common StockSEC:0001193805-18-000697:0
- 5,813,954 shares@ US$2.15100.0% of flowCommon StockSEC:0001193805-17-003457:0Canonical exit: 7 Feb 2018 (T+90)
2 of 2 declarations
